Skip to content

A feasibility trial of home-based pulmonary rehabilitation programme for adults with idiopathic pulmonary fibrosis in Delhi, India

Protocol for a single arm feasibility trial assessing home-based pulmonary rehabilitation for adults with idiopathic pulmonary fibrosis in Delhi, India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037511
Enrollment
40
Registered
2021-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

None listed

Sponsors

University of Leicester
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: People eligible for inclusion in the home-based PR trial will be: aged >=18 years,confirmed diagnosis of IPF according to ATS/ERS guidelines and willing to provide informed consent. Healthcare professionals will be defined as: Those who have at least1year of experience and work directly with IPF patients, including specialists, nurses and physiotherapists. Family caregivers will be defined as: Those who have and/or care for a family member diagnosed with IPF.

Exclusion criteria

Exclusion criteria: Adults with comorbidities such as severe or unstable cardiovascular, other internal diseases and locomotor difficulties that preclude the exercise or malignant disease or other serious illness which will interfere with participation in the study, will be excluded. Individuals not eligible for the study will be recorded on a study screening log.

Design outcomes

Primary

MeasureTime frame
Feasibility Measures to assess feasibility are provided and include the comprehensive assessment of the feasibility of patient recruitment and the intervention delivery. Acceptability The acceptability of the intervention among adults living with IPF and healthcare staff involved in its delivery will be assessed. Participantsâ?? experience of home-based PR, including any perceived benefits, challenges and changes.Timepoint: At Baseline and 8 weeks

Secondary

MeasureTime frame
Outcome measures 1. Socio-demographics 2. Lung health (spirometry data, lung transfer factor, smoking status) 3. Comorbidities 4. Treatments 5. Disease burden (MRC dyspnea grade, CAT) 6. Economic impact of disease (WPAI) 7. Quality of life (EQ-5D-5L, KBILD) 8. Psychological wellbeing (Hospital Anxiety and Depression scale) 9. Physical function (5x sit-to-stand test) 10. Exercise capacity (ISWT, ESWT) Timepoint: At baseline and 6 weeks

Countries

United Kingdom

Contacts

Public ContactMohd Shibli

Metro Centre for Respiratory Disease MCRD

dtlung@gmail.com1202533491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026